Core Viewpoint - The animal vaccine sector has shown a significant increase, with a 4.00% rise, ranking third among concept sectors, driven by notable gains in several stocks [1][2]. Group 1: Sector Performance - As of May 20, the animal vaccine concept increased by 4.00%, with 19 stocks rising, including *ST Xianfeng, which hit the daily limit, and others like Kexing Pharmaceutical, Ruipu Biological, and Kanghua Biological, which rose by 15.56%, 8.41%, and 6.70% respectively [1][2]. - The animal vaccine sector was among the top-performing sectors, alongside cultivated diamonds and pet economy, which rose by 4.10% and 4.08% respectively [2]. Group 2: Capital Inflow - The animal vaccine sector saw a net inflow of 67 million yuan, with 13 stocks receiving net inflows, and 6 stocks attracting over 10 million yuan in net inflows [2]. - Jinhe Biological led the net inflow with 36.88 million yuan, followed by Kexing Pharmaceutical, Dabeinong, and Plk, which received net inflows of 15.38 million yuan, 13.79 million yuan, and 13.60 million yuan respectively [2][3]. Group 3: Capital Flow Ratios - Stocks such as *ST Xianfeng, Kexing Pharmaceutical, and KQ Biotech had the highest net inflow ratios, at 14.17%, 6.56%, and 5.52% respectively [3]. - The top stocks in terms of capital inflow included Jinhe Biological with a turnover rate of 18.22% and a daily increase of 4.40%, and Kexing Pharmaceutical with a turnover rate of 3.46% and a daily increase of 15.56% [3][4].

Group 1 - The China Livestock Breeding Index (930707) has shown a slight increase of 0.18% as of May 19, 2025, with notable gains in stocks such as Xiangjia Co., Ltd. (002982) up by 6.62% and Yike Foods (301116) up by 1.73% [1] - The recent outbreak of highly pathogenic avian influenza in Brazil has led to a suspension of poultry imports from Brazil by Mexico, impacting the poultry market [1] - A report from Guojin Securities indicates that the price of white feather chickens has rebounded due to previous price drops and improved consumer demand, while the supply of breeding chickens has significantly decreased year-on-year [1] Group 2 - The macroeconomic policy adjustments are expected to gradually boost consumer demand, leading to an increase in poultry product consumption and a higher proportion of high-end products [2] - The dairy industry is anticipated to stabilize and recover in the second half of 2025, with ongoing low prices for raw milk and an acceleration in industry capacity reduction [2] - The top ten weighted stocks in the China Livestock Breeding Index account for 69.38% of the index, with companies like Haida Group (002311) and Muyuan Foods (002714) being the most significant contributors [3]

本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP， 参与本次互动交流，活动时间为 2025 年 5 月 23 日（周五）15:00-17:30。届时公 司高管将在线就公司 2024 年度业绩、公司治理、发展战略、经营状况、融资计划 和可持续发展等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者 踊跃参与！ 特此公告。 天康生物 证券代码：002100 证券简称：天康生物 公告编号：2025-031 天康生物股份有限公司 关于参加新疆辖区上市公司 2025 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 为进一步加强与投资者的互动交流，天康生物股份有限公司（以下简称"公 司"）将参加由新疆上市公司协会根据新疆证监局工作部署，联合深圳市全景网 络有限公司举办的"2025 年新疆辖区上市公司投资者网上集体接待日活动"，现 将相关事项公告如下： 天康生物股份有限公司董事会 2025 年 5 月 17 日 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [2] Core Viewpoints - In April 2025, the national average selling price of live pigs was 14.80 yuan/kg, with a month-on-month increase of 1.33% and a year-on-year decrease of 1.95% [6][18] - The supply gap in May is expected to lead to a further increase in the price center of live pigs, driven by limited increases in supply and improving demand [6][18] - The average weight of pigs sold is expected to gradually decline, but the narrowing price difference between different grades of pigs will have limited pressure on prices [7][22] Summary by Sections Industry Overview - April saw a non-seasonal increase in pig prices, with expectations for further price increases in May due to supply constraints and improving demand [6][18] - The average price of live pigs in April was 14.80 yuan/kg, with a month-on-month increase of 1.33% [6][18] - The slaughter volume in April was 4.213 million heads, a month-on-month decrease of 4.54% but a year-on-year increase of 6.76% [6][18] Supply and Demand Dynamics - The supply of pigs is expected to be limited in May due to previous culling and disease impacts, while demand for pork is showing marginal improvement [6][18] - The planned output for May is expected to increase by 1.98% compared to actual output in April [6][18] Profitability and Market Performance - The average profit for self-bred pigs in April was 69.44 yuan/head, a month-on-month increase of 63.63% [8][26] - The number of breeding sows in April increased by 0.96% month-on-month [8][26] - The price of 15kg piglets reached 630 yuan/head, indicating a high price level during the replenishment season [8][26] Company Performance - In April, 12 listed pig farming companies collectively sold 16.2368 million pigs, a year-on-year increase of 37.22% [9][28] - Major companies such as Muyuan Foods and Wens Foodstuffs reported significant year-on-year increases in sales volume [9][28] - The average selling prices varied among companies, with some experiencing increases while others saw declines [9][35]

Group 1: Business Performance - In 2024, the company's feed business sales volume increased by 0.87%, while the pig farming business saw a 7.55% increase in annual output, reaching 3.0285 million pigs [2][3] - The average selling price of pigs increased by 10.5% compared to the previous year, leading to a higher revenue share from pig farming [2][3] - The company plans to sell 2.9 million tons of feed and aims for a pig output of 3.5 to 4 million heads in 2025 [2][3] Group 2: Research and Development - The company has obtained 28 national new veterinary drug certificates, focusing on improving pig breeding quality and feed formulation [3][5] - Significant R&D achievements include the development of a gene-engineered inactivated vaccine for swine fever, which is a first in the country [5][6] - The company is committed to enhancing its competitive edge through continuous R&D investments in core business areas [3][5] Group 3: Future Growth Strategies - The company plans to expand its feed, pig farming, and agricultural product businesses, leveraging its strategic location to explore markets in Central Asia [3][4] - Future growth will also involve potential mergers and acquisitions based on market conditions [4][6] - The company aims to diversify its business by exploring related fields such as pet feed and vaccines [7][9] Group 4: Financial Goals and Market Position - The company's operational targets for 2025 include a total revenue of 21 billion yuan, with specific goals for feed production, animal vaccines, and corn storage [7][9] - The company has opened over 70 direct sales stores and counters in the northwest and north China regions [11][12] - The company is focused on improving its market value through enhanced governance and investor communication [12][13]

Group 1 - The animal vaccine sector saw an increase of 1.28%, ranking 8th among concept sectors, with 13 stocks rising, including Reap Bio, Blue Biological, and Yongshun Biological, which rose by 6.01%, 4.42%, and 4.36% respectively [1][2] - The leading stocks in terms of net inflow of main funds were Reap Bio with a net inflow of 9.98 million yuan, followed by Tiankang Biological, Kexing Pharmaceutical, and Biological Shares with net inflows of 9.45 million yuan, 5.12 million yuan, and 1.64 million yuan respectively [2][3] - The main fund inflow ratios were led by Shunlian Biological, Kexing Pharmaceutical, and Tiankang Biological, with net inflow ratios of 7.59%, 5.97%, and 5.13% respectively [3] Group 2 - The stocks with the largest declines included *ST Xianfeng, Haili Biological, and Ronioushan, which fell by 4.97%, 0.72%, and 0.66% respectively [1][4] - The overall trend in the animal vaccine sector indicates a mixed performance, with some stocks experiencing significant gains while others faced declines [1][4] - The trading volume and turnover rates varied significantly among the stocks, with some showing high turnover rates despite negative price movements [4]

Investment Rating - The report initiates coverage of the agriculture sector with an "Overweight" rating, indicating a favorable outlook for the industry due to stable demand and strong policy support [3][5]. Core Views - The agriculture sector is seen as a defensive investment option amidst a complex external environment, with many meat protein and agricultural product prices currently in a recovery phase, suggesting potential for stable growth in leading companies [3]. - The report highlights that low costs are a core competitive advantage for listed pig farming companies, recommending a focus on firms with strong cost control or clear cost reduction paths [3]. - The report suggests monitoring specific companies across various segments, including pig farming, poultry, feed, and agricultural products, indicating a diversified investment approach [3]. Summary by Sections Market Review - The agriculture sector underperformed the market by 1.02 percentage points during the week of May 6-9, 2025, with the index closing at 2,619.30, reflecting a 0.99% increase [14]. - Among sub-sectors, the fishery sector performed best with a 3.87% increase, while the breeding sector saw a slight decline of 0.19% [16][18]. Key Industry Data Pig Farming - As of May 9, 2025, the average price of live pigs was 14.82 CNY/kg, down 0.13% from April 30, 2025, and down 0.74% year-on-year [1]. - The profit from self-breeding was 84.33 CNY per head, while the profit from purchasing piglets increased by 9.92 CNY to 58.46 CNY per head [1]. Poultry - As of May 9, 2025, the average price of broiler chicks was 2.91 CNY per chick, up 0.34% week-on-week, while the price of white feather broilers was 7.45 CNY/kg, down 0.40% [2]. Agricultural Products - As of May 9, 2025, the average prices for key crops were as follows: wheat at 2,460.67 CNY/ton (up 0.19%), japonica rice at 2,864.00 CNY/ton (up 0.21%), corn at 2,292.86 CNY/ton (up 1.78%), and soybean meal at 3,300.00 CNY/ton (down 5.08%) [2]. Company Announcements - Muyuan Foods reported selling 6.573 million pigs in April 2025, a year-on-year increase of 51.80%, with an average selling price of 14.66 CNY/kg [35][36]. - Shennong Development achieved a sales revenue of 1.533 billion CNY in April 2025, a year-on-year increase of 0.68% [37].

Core Viewpoint - The livestock farming index in China has shown a slight decline, with specific stocks experiencing mixed performance, while external factors such as foot-and-mouth disease in South Africa are impacting the industry [1][3]. Group 1: Market Performance - As of May 13, 2025, the China Livestock Farming Index (930707) decreased by 0.38%, with stocks like Luyouli (300381) and Jinxinnong (002548) showing gains of 1.07% and 1.05% respectively, while Ruipubio (300119) led the decline with a drop of 2.66% [1]. - The Livestock ETF (516760) fell by 0.80%, with a latest price of 0.62 yuan, but it ranked first in weekly performance among comparable funds as of May 12, 2025 [1]. - The Livestock ETF had a turnover rate of 1.07% during the trading session, with a total transaction value of 1.4475 million yuan, and an average daily transaction of 4.6547 million yuan over the past year [3]. Group 2: Industry Insights - The South African Department of Agriculture confirmed the spread of foot-and-mouth disease to provinces like KwaZulu-Natal, prompting China's Ministry of Agriculture to urge livestock farmers to restrict animal transport and implement a 28-day quarantine for new animals [1]. - Everbright Securities identified three main investment themes: (1) Planting: Rising prices of staple crops like corn and wheat are expected to benefit major planting companies; (2) Seeds: Improved demand in the seed industry due to favorable planting conditions; (3) Agricultural Chemicals: Improved planting profits are likely to reduce agricultural input cost pressures, expanding the agricultural chemicals market [1]. Group 3: Valuation Metrics - The Livestock ETF closely tracks the China Livestock Farming Index, which includes companies involved in animal feed, veterinary drugs, and livestock farming, reflecting the overall performance of related listed companies [3]. - As of May 12, 2025, the Livestock Farming Index's price-to-earnings ratio (PE-TTM) was 12.26, indicating it is at a historical low, being below 99.43% of the time over the past year [3]. - The top ten weighted stocks in the Livestock Farming Index accounted for 69.38% of the index, with Hai Da Group (002311) having the highest weight at 11.24% [3][5].

Core Viewpoint - TianKang Biological has shown significant growth in its pig farming business, with a notable increase in sales and profitability in the first quarter of 2025, indicating a strong recovery in the industry [1][2][3]. Sales Performance - In April 2025, TianKang sold 244,700 pigs, a month-on-month decrease of 3.93% but a year-on-year increase of 1.58% [1]. - The sales revenue for April reached 380 million yuan, reflecting a month-on-month growth of 1.06% and year-on-year stability [1]. - Cumulatively, from January to April 2025, the company sold 1,055,400 pigs, an 18.84% increase compared to the same period last year, with total sales revenue of 1.557 billion yuan, up 11.61% year-on-year [1]. Profitability and Cost Structure - The gross margin for the pig farming sector improved significantly from -13.82% in 2023 to 14.61% in 2024, with further profitability expected in Q1 2025 [2]. - The total cost of pig farming for the company was 13.01 yuan/kg in Q1, with costs dropping below 13 yuan/kg in January and March [2]. - Comparatively, leading competitors like Muyuan and Wens have also seen reductions in their farming costs, indicating a competitive landscape [2]. Dividend and Valuation - TianKang's dividend distribution plan for 2024 proposes a payout of 2.2 yuan per 10 shares, with a dividend rate close to 50%, positioning it as a leader in the industry [3]. - The latest dividend yield stands at 3.46%, making it the second highest in the pig farming sector, just behind Muyuan [3][4]. - The valuation of pig farming stocks is currently at historical lows, suggesting potential for long-term investment growth [3]. Future Growth Potential - The company plans significant capital expenditures in pig farming and minor upgrades in feed business, with a new breeding project expected to be operational by the second half of the year [8]. - The feed business aims to reach a sales target of 5 million tons within 3-5 years, indicating a strategic growth plan [8]. - In the animal vaccine sector, the company is innovating its sales model and targeting international markets, particularly in Central Asia and Southeast Asia, to enhance its long-term growth prospects [8]. Shareholder Confidence - The controlling shareholder, Xinjiang Production and Construction Corps, plans to increase its stake in TianKang, demonstrating confidence in the company's future development [7].

Core Insights - TianKang Biological (002100.SZ) reported a mixed performance in 2024, with revenue declining by 9.72% to 17.176 billion yuan, while net profit surged by 144.38% to 605 million yuan, reflecting a strategic shift in business focus amidst industry challenges [2][3] Revenue Breakdown - The feed business, a traditional pillar for TianKang, saw sales revenue drop by 17.67% to 5.345 billion yuan, accounting for 31.12% of total revenue, primarily due to weakened demand from the livestock sector and increased raw material price volatility [2] - In contrast, the pig farming and food processing segment became the largest revenue contributor with sales of 6.157 billion yuan, achieving an 11.11% year-on-year growth, driven by improved production efficiency and rising pig prices [3] Operational Efficiency - TianKang's pig farming segment achieved a record high gross margin in nearly four years, with a total of 3.0285 million pigs sold and a reduction in production costs from 15.99 yuan/kg at the beginning of the year to 13.12 yuan/kg by year-end, showcasing effective cost management [3] Strategic Initiatives - The company is exploring collaborative solutions across its supply chain, emphasizing the integration of feed, vaccines, and farming services to provide comprehensive support for livestock farmers [3]